Jennifer Glennon
Keine laufenden Positionen mehr
Karriereverlauf von Jennifer Glennon
Ehemalige bekannte Positionen von Jennifer Glennon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EVELO BIOSCIENCES, INC. | Geschäftsführer | 01.08.2015 | 01.11.2018 |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | 01.01.2012 | 01.01.2015 |
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Finanzdirektor/CFO | 01.03.2008 | 30.11.2011 |
Ausbildung von Jennifer Glennon
INSEAD | Undergraduate Degree |
Statistik
International
Dänemark | 3 |
Vereinigte Staaten | 2 |
Frankreich | 2 |
Operativ
Director of Finance/CFO | 1 |
Chief Operating Officer | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Finance | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EVELO BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Finance |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
- Börse
- Insiders
- Jennifer Glennon
- Erfahrung